All In Biotech

Free tool

FAERS Monitor: Kinevac

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017697 or its brand name (Kinevac, Sincalide). Reports on generic versions are filed under their own applications.

Reports

153

Serious

38

25% of reports

Hospitalization

17

Death reported

1

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective38
  • drug effect decreased35
  • multiple use of single-use product29
  • no adverse event24
  • nausea13
  • product quality issue11
  • therapeutic product effect decreased11
  • diarrhoea8
  • gallbladder disorder8
  • pain8
  • abdominal pain7
  • chills7
  • dizziness7
  • hepatobiliary scan abnormal7
  • product physical consistency issue7

Reports by year received

View as table
YearReports
20041
20052
20073
20091
20101
20114
20122
201312
201437
201514
201620
20177
201810
201920
20204
20213
20221
20232
20246
20263

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,006 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hepatobiliary scan abnormalSignal78027.13809.045,767
multiple use of single-use productSignal29713.8513.819,837
product physical consistency issueSignal7174.184.41,037
drug effect decreasedSignal3589.466.82,977
gallbladder disorderSignal861.631.4419
therapeutic product effect decreasedSignal1133.819.1318
no adverse eventSignal2418.212.6377
product quality issueSignal1111.16.392
chillsSignal78.24.038
abdominal painSignal74.12.014
drug ineffectiveSignal384.03.087
nauseaSignal132.31.38
dizziness71.90.92
pain81.80.92
diarrhoea81.70.92

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.